+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Coronary Calcium. A Comprehensive Understanding of Its Biology, Use in Screening, and Interventional Management

  • Book

  • August 2019
  • Elsevier Science and Technology
  • ID: 4700339

Coronary Calcium: A Comprehensive Understanding of Its Biology, Use in Screening, and Interventional Management provides a comprehensive update on the current understanding of the significance of coronary artery calcification, showing the connection to the development of advanced atherosclerosis that will lead to better risk evaluations. Coverage includes information on the basic science behind the development of coronary calcium in atherosclerotic lesions, the pathology of calcified coronary lesions in humans, its differential development by race, and its relationship to plaque progression. Computed tomography is also covered to show the significance of coronary calcium for risk prediction and the potential role of various pharmacologic interventions.

Each chapter contains summaries with salient and important points, making this book perfect for researchers and physicians interested in the field of vascular calcification.

Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.

Table of Contents

1. Types and Pathology of Vascular Calcification 2. Calcification and Atherosclerosis Progression 3. Basic Molecular Mechanisms of Vascular Calcification 4. CT and Calcification: Understanding its Role in Risk Prediction 5. Intravascular Imaging and Coronary Calcification 6. Influence of Race and Other Risk Factors such as Diabetes and Renal Failure on Coronary Calcification 7. Vascular Calcification in Response to Pharmacologic Intervention 8. Clinical Perspective 9. Imaging of Vascular Calcification: Where Are We Headed?

Authors

Aloke Virmani Finn Director and Chief Scientific Officer, CVPath. Dr. Virmani is a physician-scientist whose focus is on the pathology of cardiovascular disease and its treatment.?He serves as the Medical Director and Chief Scientific Officer for CVPath Institute where he oversees device development research and runs a molecular lab with focus on the molecular understanding of vascular wall injury and healing, genetics of sudden cardiac death and molecular basis of coronary artery disease.? When not running CVPath, he performs interventional cardiology procedures at University of Maryland.